Category: Finance
Medtech Imricor ‘laying the foundations’ for growth after momentum builds in Q1 CY24
Imricor reactivates hospital customer sites in Q1 CY24 with momentum building Company progresses pivotal VISABL-AFL trial during quarter required for US FDA approval IMR receives [more…]
Double Whammy: Lycaon raises $2.5m, secures government funding to drill niobium-REE targets near WA1’s Luni discovery
Lycaon Resources has raised $2.5m via placement to existing and new investors The company is also a beneficiary of the WA government’s EIS funding initiative [more…]
Rio-backed Sovereign Metals increases graphite, rutile bulk sampling as part of commercialisation strategy
Industrial scale concentrator to be installed at Sovereign Metals’ Lilongwe testing facility for bulk sampling Spiral throughput capacity of up to 10 tonnes per hour [more…]
52pc premium: Lithium Energy scores top marks on value creation with sale of Solaroz for $97m
Deal reached to sell Solaroz lithium brine project for $97m Sale represents a 52% premium to Lithium Energy’s one month VWAP Company to consider investment [more…]
TG Metals has a 20Mt exploration target on Burmeister, a potential top 10 Australian hard rock lithium deposit
Burmeister deposit’s exploration target of 15.6-20.1Mt at 0.97-1.19% Li2O is large enough for a standalone operation Deposit is also just the first of several high [more…]
Top 10 at 10: Which lithium hopeful just inked an offtake with one of the world’s biggest battery makers?
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. [more…]
ASX Quarterly Tech Wrap: Altech advances CERENERGY batteries, iCandy achieves record cash receipts
It’s the quarterly season again as the ASX market announcements page becomes increasingly flooded with update lodgements. To save you the trouble of trudging through [more…]
PharmAust plans for pivotal Phase 2/3 trial after key quarter of milestones
PharmAust announces positive Phase 1 data in trial to treat MND/ALS Preliminary efficacy data shows a 58% reduction in the rate of disease progression PAA [more…]
‘Low cost, high margin, long life’: QMines delivers study to put Mt Chalmers copper project well into the profit zone
PFS at Mt Chalmers project envisages $636m free cashflow over initial 10-year life Mine to produce 65,000t copper, 160,000oz gold, 30,600t zinc and 1.8Moz silver [more…]
Bulk Buys: Is BHP’s Anglo deal a move away or back into fossil fuels?
BHP’s $60 billion bid for Anglo looks like it’s all about copper But it could also make BHP a dominant producer of premium hard coking [more…]
